Clinical trials: Formularies
Formularies
Differences Between Essential Medicines Lists in 135 Countries and Model List of Essential Medicines
The World Health Organization (WHO) has developed a model list of more than 400 medicines and recommends that each country adapt the list to its own circumstances. More than 100 countries have developed essential medicines lists.
- Trial name
- NCT03218189
- Testing
- Country characteristics
- Where
- Canada
- Volunteers
- 137 people, healthy volunteers welcome
- Sponsor
- Unity Health Toronto
Coronary Disease, Stroke
Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study
The purpose of this study is to determine the effect of two novel interventions; (1) a value-based formulary which eliminates copayment for selected high-value medications (proven to prevent heart attacks, stroke, and…
- Conditions
- Coronary Disease, Stroke, Chronic Kidney Disease, Heart Failure
- Trial name
- ACCESS (NCT02579655)
- Testing
- Copayment Elimination, Personalized Education
- Where
- Canada
- Volunteers
- 4,764 people
- Sponsor
- University of Calgary
Pediculosis Capitis, Lice Infestations
A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation
The purpose of this study is to evaluate the safety and efficacy of Vamousse Spray 'n' Go, compared to a 1% Permethrin control shampoo, in the treatment of head lice.
- Conditions
- Pediculosis Capitis, Lice Infestations, Head Lice
- Trial name
- NCT05565820
- Testing
- Vamousse Spray 'n' Go, Nix Creme Rinse Lice Treatment
- Where
- United States
- Volunteers
- 58 people
- Sponsor
- Alliance Pharmaceuticals
Chronic Heart Failure
Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.
This was a retrospective cohort study utilizing IQVIA open-source pharmacy and medical claims data among patients with a sacubitril/valsartan (SAC/VAL) prescription transaction.
- Trial name
- NCT05848206
- Where
- United States
- Volunteers
- 251,831 people
- Sponsor
- Novartis Pharmaceuticals
Value-Based Health Insurance
Evaluating the Impact of a Value-based Prescription Drug Formulary
The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency…
- Trial name
- VBF-e (NCT04904055)
- Testing
- Value-based Formulary
- Where
- United States
- Volunteers
- 36,333 people
- Sponsor
- Kaiser Permanente